Showing results (241-250 of 824) with videos related to
Sort By:
Pageof 83
British Journal of Haematology|April 10, 2008
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implicationsKenji Ishitsuka, Teru Hideshima, Paola Neri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomibMelissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.Blood|March 5, 2008
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.The Application of Clinical Genetics|August 13, 2013
Candidate genes of Waldenström's macroglobulinemia: current evidence and researchGiada Bianchi, Antonio Sacco, Shaji Kumar, et al.Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.Blood|October 18, 2002
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaPaul G Richardson, Robert L Schlossman, Edie Weller, et al.Leukemia & Lymphoma|August 28, 2010
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patientsMeghan Rourke, Kenneth C Anderson, Irene M GhobrialImmunotargets and Therapy|October 29, 2020
Immunotherapeutic and Targeted Approaches in Multiple MyelomaOmar Nadeem, Yu-Tzu Tai, Kenneth C AndersonExpert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonMolecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonPageof 83